Oral propranolol as a new treatment for facial infantile hemangioma: case report

Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.

Saved in:
Bibliographic Details
Main Authors: Ferreira,Rosane da Cruz, Wolff,Francisco Romeu Locatelli, Mörschbächer,Ricardo
Format: Digital revista
Language:English
Published: Conselho Brasileiro de Oftalmologia 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-27492011000300012
record_format ojs
spelling oai:scielo:S0004-274920110003000122011-09-02Oral propranolol as a new treatment for facial infantile hemangioma: case reportFerreira,Rosane da CruzWolff,Francisco Romeu LocatelliMörschbächer,Ricardo Hemangioma Hemangioma, capillary/therapy Propranolol/therapeutic use Case reports Infant, newborn Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.info:eu-repo/semantics/openAccessConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia v.74 n.3 20112011-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012en10.1590/S0004-27492011000300012
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ferreira,Rosane da Cruz
Wolff,Francisco Romeu Locatelli
Mörschbächer,Ricardo
spellingShingle Ferreira,Rosane da Cruz
Wolff,Francisco Romeu Locatelli
Mörschbächer,Ricardo
Oral propranolol as a new treatment for facial infantile hemangioma: case report
author_facet Ferreira,Rosane da Cruz
Wolff,Francisco Romeu Locatelli
Mörschbächer,Ricardo
author_sort Ferreira,Rosane da Cruz
title Oral propranolol as a new treatment for facial infantile hemangioma: case report
title_short Oral propranolol as a new treatment for facial infantile hemangioma: case report
title_full Oral propranolol as a new treatment for facial infantile hemangioma: case report
title_fullStr Oral propranolol as a new treatment for facial infantile hemangioma: case report
title_full_unstemmed Oral propranolol as a new treatment for facial infantile hemangioma: case report
title_sort oral propranolol as a new treatment for facial infantile hemangioma: case report
description Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.
publisher Conselho Brasileiro de Oftalmologia
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492011000300012
work_keys_str_mv AT ferreirarosanedacruz oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport
AT wolfffranciscoromeulocatelli oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport
AT morschbacherricardo oralpropranololasanewtreatmentforfacialinfantilehemangiomacasereport
_version_ 1756373144745017344